sgRNA for up-regulating non-coding RNA expression in human DLK1-DIO3 imprinted domain, recombinant plasmid and cell line
A DLK1-DIO3, recombinant plasmid technology, applied in the field of special sgRNA primer sequences
- Summary
- Abstract
- Description
- Claims
- Application Information
 AI Technical Summary 
Problems solved by technology
Method used
Image
Examples
specific Embodiment
[0027] Bladder cancer UM-UC-3 cells in good growth state were cultured. The UM-UC-3 cells were plated one day before virus infection. On the day of infection, dCAS9-VP64 lentiviral particles were added to the groups designed for the experiment to infect the target cells. Puromycine screening was performed 3 days after infection, followed by infection with sgRNA (DLK1-DIO3) lentivirus, G418 screening, and cell collection for detection or related functional studies.
PUM
 Login to View More
 Login to View More Abstract
Description
Claims
Application Information
 Login to View More
 Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



